Clinical Research Facility
				
				Ames, Iowa 50010
We've found
        6 trials
        at this facility
      	
	Advanced Solid Malignancies Clinical Trial
	
Updated: 12/31/1969
  
  
  An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	MPN (Myeloproliferative Neoplasms) Clinical Trial
	
Updated: 12/31/1969
  
  
  Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Relapsed/Refractory Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Herpes Zoster Clinical Trial
	
Updated: 3/10/2015
  
  
  A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 3/10/2015
Click here to add this to my saved trials
	    
	